These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 22084906)
1. Matrix metalloproteinases in plants: a brief overview. Marino G; Funk C Physiol Plant; 2012 May; 145(1):196-202. PubMed ID: 22084906 [TBL] [Abstract][Full Text] [Related]
2. C1A cysteine-proteases and their inhibitors in plants. Martínez M; Cambra I; González-Melendi P; Santamaría ME; Díaz I Physiol Plant; 2012 May; 145(1):85-94. PubMed ID: 22221156 [TBL] [Abstract][Full Text] [Related]
3. Family-wide characterization of matrix metalloproteinases from Arabidopsis thaliana reveals their distinct proteolytic activity and cleavage site specificity. Marino G; Huesgen PF; Eckhard U; Overall CM; Schröder WP; Funk C Biochem J; 2014 Jan; 457(2):335-46. PubMed ID: 24156403 [TBL] [Abstract][Full Text] [Related]
4. Labeling and enrichment of Arabidopsis thaliana matrix metalloproteases using an active-site directed, marimastat-based photoreactive probe. Lenger J; Kaschani F; Lenz T; Dalhoff C; Villamor JG; Köster H; Sewald N; van der Hoorn RA Bioorg Med Chem; 2012 Jan; 20(2):592-6. PubMed ID: 21775155 [TBL] [Abstract][Full Text] [Related]
5. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases]. Hamacher S; Matern S; Roeb E Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740 [TBL] [Abstract][Full Text] [Related]
6. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Bode W; Maskos K Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053 [TBL] [Abstract][Full Text] [Related]
8. Subtilases - versatile tools for protein turnover, plant development, and interactions with the environment. Schaller A; Stintzi A; Graff L Physiol Plant; 2012 May; 145(1):52-66. PubMed ID: 21988125 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in vascular physiology and disease. Siefert SA; Sarkar R Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Gueders MM; Foidart JM; Noel A; Cataldo DD Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964 [TBL] [Abstract][Full Text] [Related]
11. Senescence-associated proteases in plants. Roberts IN; Caputo C; Criado MV; Funk C Physiol Plant; 2012 May; 145(1):130-9. PubMed ID: 22242903 [TBL] [Abstract][Full Text] [Related]
12. [Structure and function of matrix metalloproteinases]. Olszyński K; Zimowska M Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468 [TBL] [Abstract][Full Text] [Related]
13. Biology of metalloproteinases. Amălinei C; Căruntu ID; Bălan RA Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181 [TBL] [Abstract][Full Text] [Related]
14. Role of matrix metalloproteinases in melanoma cell invasion. Hofmann UB; Houben R; Bröcker EB; Becker JC Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317 [TBL] [Abstract][Full Text] [Related]
15. Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis. Keeling J; Herrera GA Microsc Res Tech; 2008 May; 71(5):371-9. PubMed ID: 18300288 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in atherothrombosis. Bäck M; Ketelhuth DF; Agewall S Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and their role in oncogenesis: a review. Pytliak M; Vargová V; Mechírová V Onkologie; 2012; 35(1-2):49-53. PubMed ID: 22310347 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Visse R; Nagase H Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128 [TBL] [Abstract][Full Text] [Related]
19. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401 [TBL] [Abstract][Full Text] [Related]
20. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Janssens S; Lijnen HR Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]